Status | Study |
Not yet recruiting |
Study Name: Erythrocyte Glutamine/Glutamate Ratio Relation to Pulmonary Hypertension Risk in Thalassemic Children Condition: Thalassemia in Children Pulmonary Hypertension Hemolysis Date: 2017-04-15 Interventions: Diagnostic Test: Erythrocyte glutamine/glutamate ratio |
Recruiting |
Study Name: Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease Condition: Sickle Cell Disease Date: 2017-04-14 Interventions: Drug: ATG 0.5 mg/kg IV on day |
Recruiting |
Study Name: Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization. Condition: Sickle Cell Disease Date: 2017-04-07 Interventions: Biological: Inactivated influenza A (H1N1) virus vaccine |
Recruiting |
Study Name: Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders Condition: Severe Sickle Cell Disease Bone Marrow Failure Syndromes M Date: 2017-04-03 Interventions: Drug: RIC regimen Days -60 to |
Completed |
Study Name: Zinc Supplementation on Cellular Immunity in Thalassemia Major Condition: Thalassemia Splenectomy; Status Immunosuppression Date: 2017-03-31 Interventions: Drug: Zinc Sulfate Zinc supple |
Recruiting |
Study Name: Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose Condition: Sickle Cell Anemia Sickle Cell Disease Date: 2017-03-30 |
Recruiting |
Study Name: Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism Condition: Beta Thalassemia Major Date: 2017-03-26 Interventions: Drug: Interleukin-2 On +60 day |
Recruiting |
Study Name: Acute Kidney Injury in Patients With Sickle Cell Disease Condition: Sickle Cell Disease Kidney Injury Kidney Diseases Date: 2017-03-23 |
Not yet recruiting |
Study Name: Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas Condition: Sickle Cell Anemia Sickle Cell Disease Malaria Date: 2017-03-22 Interventions: Drug: Hydroxyurea Administered once a day in tablet form (100mg or scored 1000mg) for 24 months |
Completed |
Study Name: Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia Condition: Thalassemia Pneumococcal Infection Date: 2017-03-15 Interventions: Dietary Supplement: Zinc formu |